Novel perspective in pancreatic cancer therapy: Targeting ferroptosis pathway

被引:0
|
作者
Yang Yang [1 ]
Zi-Jian Zhang [1 ]
Yu Wen [1 ]
Li Xiong [1 ]
Yun-Peng Huang [1 ]
Yong-Xiang Wang [1 ]
Kai Liu [1 ]
机构
[1] Department of General Surgery, The Second Xiangya Hospital, Central South University
基金
中国国家自然科学基金;
关键词
D O I
暂无
中图分类号
R735.9 [胰腺肿瘤];
学科分类号
100214 ;
摘要
Pancreatic cancer is a highly lethal malignancy with low resection and survival rates and is not sensitive to radiotherapy and chemotherapy. Ferroptosis is a novel form of nonapoptotic regulated cell death characterized by the accumulation of lipid peroxides and reactive oxygen species involved in iron metabolism.Ferroptosis has a significant role in the occurrence and development of various tumors. Previous studies have shown that regulating ferroptosis-induced cell death inhibited tumor growth in pancreatic cancer and was synergistic with other antitumor drugs to improve treatment sensitivity. Herein, we discuss the mechanism, inducers, and developments of ferroptosis in pancreatic cancer to provide new strategies for the treatment of the malignancy.
引用
收藏
页码:1668 / 1679
页数:12
相关论文
共 50 条
  • [41] Natural products targeting ferroptosis pathways in cancer therapy (Review)
    Na, Xin
    Li, Lin
    Liu, Dongmei
    He, Jiaqi
    Zhang, Ling
    Zhou, Yiping
    ONCOLOGY REPORTS, 2024, 52 (03)
  • [42] Targeting ferroptosis for cancer therapy: iron metabolism and anticancer immunity
    Luo, Lianxiang
    Wang, Han
    Tian, Wen
    Zeng, Jiayan
    Huang, Yuru
    Luo, Hui
    AMERICAN JOURNAL OF CANCER RESEARCH, 2021, 11 (11): : 5508 - 5525
  • [43] Targeting pancreatic cancer stem cells for cancer therapy
    Xia, Jun
    Chen, Changjie
    Chen, Zhiwen
    Miele, Lucio
    Sarkar, Fazlul H.
    Wang, Zhiwei
    BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER, 2012, 1826 (02): : 385 - 399
  • [44] Targeting the mevalonate pathway, a novel anti-ferroptosis pathway, in hepatocellular carcinoma (HCC) treatment
    Chen, Yiling
    Lee, Derek
    Zhang, Misty Shuo
    Cheu, Jacinth Wing-Sum
    Wong, Carmen Chak-Lui
    CANCER RESEARCH, 2023, 83 (07)
  • [45] Agents targeting the Hedgehog pathway for pancreatic cancer treatment
    Bisht, Savita
    Brossart, Peter
    Maitra, Anirban
    Feldmann, Georg
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2010, 11 (12) : 1387 - 1398
  • [46] Targeting of oncogenic microARNs for pancreatic cancer therapy
    Sicard, F.
    Buscail, L.
    Cordelier, P.
    BULLETIN DU CANCER, 2010, 97 : S60 - S60
  • [47] Novel targeting methods for pancreatic cancer.
    Knowlton, Andrea
    Restuccia, Antonietta
    Delitto, Daniel
    Trevino, Jose
    Hudalla, Greg
    Wallet, Shannon
    JOURNAL OF IMMUNOLOGY, 2015, 194
  • [48] Targeting Keratin 17 in Pancreatic Cancer: A Novel Rewired Pathway of Nucleotide Metabolism that Drives Chemoresistance
    Pan, Chun-Hao
    Tseng, Robert
    Donnelly, Katie
    Leiton, Cindy V.
    Hogg, Simon J.
    Marchenko, Natalia
    Singh, Pankaj K.
    Shroyer, Kenneth R.
    Escobar-Hoyos, Luisa F.
    FASEB JOURNAL, 2022, 36
  • [49] Targeting Bcl-2-Mediated Cell Death as a Novel Therapy in Pancreatic Cancer
    Muilenburg, Diego J.
    Coates, Jodi M.
    Virudachalam, Subbulakshmi
    Bold, Richard J.
    JOURNAL OF SURGICAL RESEARCH, 2010, 163 (02) : 276 - 281
  • [50] Targeting the EGFR signaling pathway in cancer therapy
    Seshacharyulu, Parthasarathy
    Ponnusamy, Moorthy P.
    Haridas, Dhanya
    Jain, Maneesh
    Ganti, Apar K.
    Batra, Surinder K.
    EXPERT OPINION ON THERAPEUTIC TARGETS, 2012, 16 (01) : 15 - 31